Board of Directors

Susannah Gray Former Executive Vice President, Finance & Strategy, Royalty Pharma Management

Susannah Gray brings more than 30 years of biopharmaceutical experience specifically in corporate finance and capital markets roles, most recently serving as EVP, Finance & Strategy of Royalty Pharma Management, LLC. Ms. Gray spent 14 years as Executive Vice President and Chief Financial Officer of Royalty Pharma before retiring in 2019 just ahead of the Company’s initial public offering. At Royalty Pharma, Ms. Gray led the Company’s efforts to maximize its financial capabilities. In her career at Royalty Pharma, she increased the debt facilities from approximately $200 million to $7 billion, and was responsible for over $20 billion in total financing. She also raised $2.0 billion equity capital for the Company.

Prior to joining Royalty Pharma, Ms. Gray had a 14-year career in investment banking. In her most recent role, she was a Managing Director and the Senior Analyst covering the healthcare sector for CIBC World Market’s high yield group from 2002 to 2004. She worked in a similar capacity at Merrill Lynch prior to joining CIBC World Markets. Ms. Gray joined Merrill Lynch in April 1999 after nine years at Chase Securities (a predecessor of JP Morgan), working in various capacities within the high yield and the structured finance groups. Ms. Gray received a BA with honors from Wesleyan University and holds an MBA degree from Columbia University. Ms. Gray currently serves on the board of directors of Susan G. Komen and is on the board of trustees at Wesleyan University.

Board Observers

Ahmed Kizer Khan Chief Executive Officer - Daman Investments & Board Advisor

Mr. Ahmed Khizer Khan is the CEO of Daman Investments, a pioneer firm in the UAE's financial services industry. Mr. Khan is a globally recognized business leader, banker and change agent with over three decades of global leadership experience. After an Honors degree in Economics from Bucknell, and an MBA from Rutgers, he spent his formative years in USA, Central Europe, UAE, and Pakistan with PWC and Citibank; before joining Barclays Global Retail and Commercial Bank as its Chief Executive, Emerging Markets, responsible for 15 countries including high-growth markets like India, UAE, Africa, Russia, Pakistan and Indonesia.

Mr. Khan served on the Barclays Board for several countries, working with the Global Chairman on formulating strategies for the emerging markets. After an impactful stint at the Islamic Corporation for the Development of the Private Sector, Jeddah, as its COO & Director Coverage, Partnerships and Syndication, across 35 countries; he became the President & Chief Executive Officer of Burj Bank Limited in Pakistan, where he turned around a small loss-making entity into the fastest growing Islamic Bank in Pakistan.

Mr. Khan, with nearly three decades of international banking industry experience, took over the reins at Daman Investments in 2016, with a mandate to re-engineer the business. Under his leadership, the company has increased footprint in new areas and won mandates for large M&A and investment banking projects. In a short span of time, he has been instrumental in achieving over 100% growth in profitability. He has led Daman Investments in conducting one of the largest leveraged buyouts within the family-owned entities in UAE. Established in 1998, Daman Investments has been actively offering investment opportunities to the institutional, high net-worth, and retail customers in UAE and beyond.

Mr. Khan is leading and managing the Gargash Group Family Office while also serving as a Board Member for Gargash Group since 2016. The Gargash Group is amongst the largest business conglomerates in UAE with more than 28 businesses across diversified industries including Automotive, Real Estate, Financial Services, F&B and several others. Currently Mr. Khan is also serving on the Board of Deem Finance LLC; a leading consumer finance business in the UAE.